In this prospective cohort of patients with acute myocardial infarction (AMI), plasma progranulin levels increased acutely ...

Valuably, the NUDGE-FLU results point to “what message will resonate with an unsure, high-risk group with a history of ...

CHICAGO, IL—Spironolactone given to patients who have undergone PCI following an acute myocardial infarction has no impact on ...

Over 2 decades ago, the aldosterone antagonist eplerenone proved beneficial after MI complicated by left ventricular ...

For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with reduced mortality, myocardial ...

According to a new study, the risk of heart failure and cardiovascular death also occurs in people who try to compensate by ...

The study highlights BMI's role in mediating genetic risk for diseases, suggesting a complex relationship with conditions ...

Delaying noncardiac surgeries for three to six months following a heart attack appears safer for those who undergo r ...

The study suggests non-fermented milk may raise ischemic heart disease risk in women, urging a closer look at dairy ...

The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.

Mean achieved blood pressure in the two groups was 120.6 mm Hg in the intensive-treatment group and 132.1 mm Hg in the ...

WASHINGTON — Colchicine does not protect against major cardiovascular adverse events after an acute myocardial infarction, according to a multinational placebo-controlled trial of more than 7000 ...